FDA Clearance Tracker · P180027-S013
Flow Re-Direction Endoluminal Device (FRED®) System
Last checked: Nov 20, 2026Latest source record: Nov 2, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Nov 2, 2025
Approved
Time to decision
178 days
Received May 8, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P180027-S013
- Device name
- Flow Re-Direction Endoluminal Device (FRED®) System
- Applicant
- MicroVention, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- May 8, 2025
- Decided
- Nov 2, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P180027
Device type
- Device type
- Intracranial aneurysm flow diverter (OUT)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the addition of the stent surface functionalization manufacturing process and to perform stent pusher loading, packaging, labeling, and sterilization on the FRED X system at the MicroVention Costa Rica manufacturing site located at Zona Franca Coyol Alajuela, Costa Rica.
Source documents
Other decisions for MicroVention, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254035 · Decided Sep 3, 2026 · 261 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.